Invokana Lawsuit | Invokana Side Effects Lawsuits | Side effects : Ketoacidosis | Other SGLT2s: jardinance, farxiga
Invokana Side Effects Attorney
Invokana Lawsuit | Invokana Side Effects Lawsuit Claims | Invokana Ketoacidosis Lawsuits, Invokana diabetic ketoacidosis Lawsuits, Invokana ketosis Lawsuits | Invokana Lawyers | Invokana Attorneys | Jardinance Lawsuits | Jardinance Side Effects Lawsuit Claims | Jardinance Ketoacidosis Lawsuits, Jardinance diabetic ketoacidosis Lawsuits, Jardinance ketosis Lawsuits | Jardinance Lawyers | Jardinance Attorneys | Farxiga Lawsuits | Farxiga Side Effects Lawsuit Claims | Farxiga Ketoacidosis Lawsuits, Farxiga diabetic ketoacidosis Lawsuits, Farxiga ketosis Lawsuits | Farxiga Lawyers | Farxiga Attorneys
Invokana, Jardinance, and Farxiga, prescription medications that treat Type 2 diabetes, may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids that may require hospitalization, according to the U.S. Food and Drug Administration (FDA). Invokana, Jardinance, and Farxiga, are in a class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. The FDA reported 20 cases of acidosis reported as diabetic ketoacidosis, ketoacidosis, or ketosis in patients treated with SGLT2 inhibitors (Invokana, Jardinance, and Farxiga) from March 2013 to June 6, 2014. In May 2015, the FDA warned patients taking Invokana, Jardinance, and Farxiga, to pay close attention to any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness. The regulatory agency directed doctors to examine patients with these symptoms to determine if they have acidosis, including ketoacidosis. The FDA said it would continue to investigate safety concerns regarding Invokana, Jardinance, and Farxiga.
Alonso Krangle LLP is investigating Invokana Side Effects Lawsuits including Jardinance lawsuits, and Farxiga lawsuits due to reports of ketoacidosis associated with taking Invokana, Jardinance, or Farxiga. The firm is offering free Invokana Side Effects Lawsuits, including Jardinance lawsuit and Farxiga lawsuit legal evaluations to those who may have developed diabetic ketoacidosis, ketoacidosis, or ketosis due to taking Invokana, Jardinance, or Farxiga. To find out the legal options available to you, please contact the Jardinance, or Farxiga or Invokana Side Effects Lawsuits Attorneys at Alonso Krangle LLP today.
The FDA and Invokana (canagliflozin), jardinance, farxiga, SGLT2 Inhibitors
Invokana (canagliflozin) is a SGLT2 inhibitor approved by the FDA in 2013 for use with diet and exercise to lower blood sugar in adults with Type 2 diabetes. Sales for Johnson Johnson’s popular drug came in at $278 million during the first quarter of 2015, almost triple the amount of sales during the same period in 2014. Invokana is in the same SGLT2 inhibitor class as other popular diabetes medications such as Farxiga (dapagliflozin), and Jardiance (empagliflozin). SGLT2 inhibitors lower blood sugar by causing the kidneys to remove sugar from the body through the urine. In September 2015, the FDA revised Invokana’s safety label to warn of an increased risk of bone fractures associated with the drug and added new information about decreased bone mineral density.
Invokana Side Effects
As an SGLT2 Inhibitor, Invokana, Jardinance, and Farxiga, diabetes drugs can cause serious side effects that include:
- Kidney failure
- Hyperkalemia (a high amount of potassium in the blood)
- Hypoglycemia (low blood sugar)
- Increased cholesterol in the blood
- Urinary tract infection
Invokana Side Effects Lawsuits
Invokana side effects lawsuits filed on behalf of patients who developed ketoacidosis and other complications, accuse Johnson Johnson and its Janssen Pharmaceuticals unit, of failing to adequately warn about Invokana’s side effects. For instance, in one recently filed complaint, a California woman alleges she developed diabetic ketoacidosis as a result of taking Invokana and was hospitalized in October 2013. The woman alleges she experienced nausea and vomiting, severe abdominal pain, severe dehydration, labored breathing, low blood pressure, and tachycardia, according to the Invokana complaint. The plaintiff claims the drug makers failed to warn prescribing physicians about the risks of Invokana use, including the risk of diabetic ketoacidosis and resulting complications.
(Case No. 2:15-cv-01102, U.S. District Court, Eastern District of California)
About Alonso Krangle LLP and Filing An Invokana Side Effects Lawsuit
Andres Alonso and David Krangle, attorneys with 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A nationwide law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and New Jersey.
The Invokana Lawyers at Alonso Krangle LLP are investigating Invokana Side Effects Lawsuits claims of patients who have been harmed by taking the prescription medication to treat Type 2 diabetes. For more information about Alonso Krangle LLP and filing an Invokana Side Effects Lawsuit, please contact us or visit our website, https://www.FightForVictims.com.